Related Experiment Videos
Neuromuscular blocking agents in neurointensive care
N Juul1, G F Morris, S B Marshall
1Division of Neurosurgery, University of California San Diego, San Diego, USA.
Acta Neurochirurgica. Supplement
|July 14, 2001
Summary
Neuromuscular blocking agents (NBA) are commonly used in severe head injury care, but this study found they were associated with longer periods of elevated intracranial pressure (ICP). This challenges their routine use in sedation strategies.
Area of Science:
- Neuroscience
- Critical Care Medicine
- Pharmacology
Background:
- Severe head injury management focuses on preventing secondary brain injury.
- Sedation and ventilation are crucial components of intensive care for these patients.
- Neuromuscular blocking agents (NBA) are frequently used to manage intracranial pressure (ICP) despite limited evidence.
Purpose of the Study:
- To evaluate the impact of Neuromuscular Blocking Agents (NBA) on intracranial pressure (ICP) in patients with severe head injury.
- To challenge the routine use of NBA in sedation protocols for severe head injury.
Main Methods:
- Retrospective analysis of data from a multicenter, randomized, double-blind trial (Selfotel study).
- Examined data on NBA infusion, ventilator treatment, and ICP measurements.
- Compared outcomes between patients who received NBA and those who did not.
Main Results:
- Patients receiving NBA had a median of 13.5 hours with ICP > 20 mm Hg.
- Patients not receiving NBA had a median of 6.5 hours with ICP > 20 mm Hg (p < 0.05).
- No demographic differences were observed between groups.
Conclusions:
- The findings question the routine use of NBA as part of sedation strategies in severe head injury.
- Current evidence does not support the widespread use of NBA for ICP management in this patient population.